Advances in the creation of animal models of paroxysmal nocturnal hemoglobinuria

References

• Rotoli B, Luzzatto L. Paroxysmal nocturnal hemoglobinuria. Semin Hematol. 1989, Jul;26(3):201–207.
   PubMed Web of Science ®Google Scholar
• Bessler M, Mason PJ, Hillmen P, et al. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 1994;13(1):110–117.
   PubMed Web of Science ®Google Scholar
• Ware RE, Rosse WF, Howard TA. Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria. Blood. 1994;83(9):2418–2422.
   PubMed Web of Science ®Google Scholar
• Ra B. How I treat paroxysmal nocturnal hemoglobinuria. Blood. 2009;113:6522–6527.
   PubMed Web of Science ®Google Scholar
• Rong F. How do I treat paroxysmal nocturnal hemoglobinuria. Chin J Hematol. 2008;39(11):887–891.
   Google Scholar
• Liyan L, Rong F. Pathogenesis of paroxysmal nocturnal hemoglobinuria. Chin J Hematol. 2008;39(6):527–528.
   Google Scholar
• Shen W, Clemente MJ, Hosono N, et al. Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria. J Clin Invest. 2014;124(10):4529–4538.
   PubMed Web of Science ®Google Scholar
• Li LY, Liu ZY, Liu H, et al. Deep sequencing of whole genome exon in paroxysmal nocturnal hemoglobinuria. Am J Hematol. 2017 Apr;4(92):E51–E53.
   Google Scholar
• Li L, Liu H, Wang H, et al. Abnormal expression and mutation of the RBPJ gene may be involved in CD59-clonal proliferation in paroxysmal nocturnal hemoglobinuria. Exp Ther Med. 2019 Jun;17(6):4536–4546.
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Mukhina GL, Nelson KL, et al. Resistance of paroxysmal nocturnal hemoglobinuria cells to the gly-cosylphosphatidylinositol-binding toxin aerolysin. Blood. 1999;93(5):1749–1756.
   PubMed Web of Science ®Google Scholar
• Fujita M, Kinoshita T. GPI-anchor remodeling: potential functions of GPI-anchors in intracellular trafficking and membrane dynamics. Biochim Biophys Acta. 2012 Aug;1821(8):1050–1058.
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Fujita M, Maeda Y. Biosynthesis, remodelling and functions of mammalian Gpi-anchored proteins: recent progress. J Biochem. 2008;144(3):287–294.
   PubMed Web of Science ®Google Scholar
• Park J, Kim M, Kim Y, et al. Clonal cell proliferation in paroxysmal nocturnal hemoglobinuria: evaluation of PIGA mutations and T-cell receptor clonality. Ann Lab Med. 2019;39(5):438–446.
   PubMed Web of Science ®Google Scholar
• Kawagoe K, Kitamura D, Okabe M, et al. Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood. 1996;87(9):3600–3606.
   PubMed Web of Science ®Google Scholar
• Rosti V, Tremml G, Soares V, et al. Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest. 1997;100(5):1028–1036.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Kinoshita T, Maeda Y, et al. Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by a mouse model of paroxysmal nocturnal hemoglobinuria. Blood. 1999;94(9):2963–2970.
   PubMed Web of Science ®Google Scholar
• Tremml G, Dominguez C, Rosti V, et al. Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene. Blood. 1999;94(9):2945–2954.
   PubMed Web of Science ®Google Scholar
• Takahama Y, Ohishi K, Tokoro Y, et al. Functional competence of T cells in the absence of glycosyl phosphatidylinositol-anchored proteins caused by T cell-specific disruption of the Pig-agene. Eur J Immunol. 1998;28(7):2159–2166.
   PubMed Web of Science ®Google Scholar
• Keller P, Payne JL, Tremml G, et al. Fes-Cre targets phosphatidylinositol glycan class a (Piga) inactivation to hematopoietic stem cells in the bone marrow. J Exp Med. 2001;194(5):581–589.
   PubMed Web of Science ®Google Scholar
• Jasinski M, Keller P, Fujiwara Y, et al. GATA1-Cre mediates Piga gene inactivation in the erythroid/megakaryocytic lineage and leads to circulating red cells with a partial deficiency in glycosyl phosphatidylinositol-linked proteins (paroxysmal nocturnal hemoglobinuria type II cells). Blood. 2001;98(7):2248–2255.
   PubMed Web of Science ®Google Scholar
• Capecchi MR. The new mouse genetics: altering the genome by gene targeting. Trends Genet. 1989;5(3):70–76.
   PubMed Web of Science ®Google Scholar
• Galli-Taliadoros LA, Sedgwick JD, Wood SA, et al. Gene knock-out technology: a methodological overview for the interested novice. J Immunol Methods. 1995;181(1):1–15.
   PubMed Web of Science ®Google Scholar
• Kühn R, Torres RM. Cre/loxP recombination system and gene targeting. Methods Mol Biol. 2002;180:175–204.
   PubMedGoogle Scholar
• Wang CH, Sun H. Progress in gene knockout mice. Sheng Wu Gong Cheng Xue Bao. 2019;35(5):784–794 (in Chinese).
   PubMedGoogle Scholar
• Kawano F, Okazaki R, Yazawa M, et al. A photoactivatable Cre-LoXP recombination system for optogenetic genome engineering. Nat Chem Biol. 2016;12(12):1059–1064.
   PubMed Web of Science ®Google Scholar
• Shin TH, Baek EJ, Corat MAF, et al. CRISPR/cas9 PIG-A gene editing in nonhuman primate model demonstrates no intrinsic clonal expansion of PNH HSPCs. Blood. 2019;133(23):2542–2545.
   PubMed Web of Science ®Google Scholar
• Mojica FJ, Ferrer C, Juez G, et al. Long stretches of short tandem repeats are present in the largest replicons of the archaea haloferax mediterranei and Haloferax volcanii and could be involved in replicon partitioning. Mol Microbiol. 1995;17(1):85–93.
   PubMed Web of Science ®Google Scholar
• Hsu PD, Lander ES, Zhang F. Development and applications of Crispr-Cas9 for genome engineering. Cell. 2014;157(6):1262–1278.
   PubMed Web of Science ®Google Scholar
• Molina H, Wong W, Kinoshita T, et al. Distinct receptor and regulatory properties of recombinant mouse 1 complement receptor (CR1) and Crry, the two genetic homologues of human CR1. J Exp Med. 1992;175(1):121–129.
   PubMed Web of Science ®Google Scholar
• Spicer AP, Seldin MF, Gendler SJ. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. J Immunol. 1995;155(6):3079–3091.
   PubMed Web of Science ®Google Scholar
• Rosse WF, Adams JP, Thorpe AM. The population of cells in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis: significance and mechanism of increased immune lysis. Br J Haematol. 1974;28(2):181–190.
   PubMed Web of Science ®Google Scholar
• Manivannan P, Ahuja A, Pati HP. Diagnosis of paroxysmal nocturnal hemoglobinuria: recent advances. Indian J Hematol Blood Transfus. 2017;33(4):453–462.
   PubMed Web of Science ®Google Scholar
• Keeney M, Illingworth A, Sutherland DR. Paroxysmal nocturnal hemoglobinuria assessment by flow cytometric analysis. Clin Lab Med. 2017;37(4):855–867.
   PubMed Web of Science ®Google Scholar
• Brodsky RA. How do pig-a mutant paroxysmal nocturnal hemoglobinuria stem cells achieve dominance. Expert Rev Hematol. 2009;2(4):353–356.
   PubMed Web of Science ®Google Scholar
• Hill A, DeZern AE, Kinoshita T, et al. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers. 2017;3(3):17028.
   PubMedGoogle Scholar
• Dahmani A, Roudot H, Cymbalista F, et al. Evaluation of fluorescently labeled aerolysin as a new kind of reagent for flow cytometry tests:optimization of use of FLAER, Hints, and Limits. Am J Clin Pathol. 2016;145(3):407–417.
   PubMed Web of Science ®Google Scholar
• Russell ES, Bernstein SE. Blood and blood formation. In: Green EL, editor. Biology of the laboratory mouse. New York: McGraw-Hill Book Company ; 1966. p. P351–372.
   Google Scholar